[13C6]-Balsalazide

[13C6]-Balsalazide is a drug used in the treatment of inflammatory bowel disease (IBD). It is a prodrug of mesalazine, which is an anti-inflammatory agent that works by inhibiting the production of prostaglandins and leukotrienes, which are responsible for inflammation in the colon. The [13C6] in the name refers to the addition of six carbon atoms to the drug molecule, which can help to track the drug's metabolism in the body. The chemical formula of [13C6]-Balsalazide is C17H16N4O8S2, with a molecular weight of 464.46 g/mol. It is typically administered orally in the form of tablets or capsules. The drug is rapidly metabolized in the body, with peak plasma levels reached within 30 minutes to one hour after administration. [13C6]-Balsalazide is generally well-tolerated, with few side effects. However, some patients may experience gastrointestinal disturbances such as nausea, vomiting, or diarrhea. In rare cases, the drug may cause hypersensitivity reactions such as rash, fever, or difficulty breathing. In conclusion, [13C6]-Balsalazide is an effective treatment option for IBD, with a well-established safety profile. Its unique chemical structure allows for tracking of its metabolism in the body, which can be useful in understanding its pharmacological properties. Patients should always consult with their healthcare provider before starting any new medication.